NEK2 and cervical cancer: To elucidate whether NEK2 is related to this classical oncogenic pathway, we examined the expression of β-catenin and found that NEK2 silencing led to significant reduction in β-catenin at the protein level in two different cervical cancer cell lines (Fig. 5e).